GeoVax Labs, Inc.
GeoVax Labs, Inc. (GOVX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GOVX · as of Jun 9, 2026
Key Statistics
Explore GeoVax Labs, Inc. Data
govx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The GOVX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $100.00, representing +7362.69% upside from the current price of $1.34.
Competitors & Peers
govx competitorsGOVX
ADAP
ADTX
AIMD
ANL
APLMStock Performance
Full HistoryAbout GeoVax Labs, Inc.
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various…
what is geovax labs, inc. · govx stock overview · geovax labs, inc. company profile · who is geovax labs, inc. ceo · govx NASDAQ · geovax labs, inc. headquarters · geovax labs, inc. business segments
About Stock Overview & Key Data
GeoVax Labs, Inc. (GOVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 25, 2020. As of the latest trading session, GOVX stock price is $1.34, with a market capitalization of $1.3M. The stock has returned -95.46% over the past 12 months and -68.69% year-to-date.
According to 7 Wall Street analysts, the consensus rating for GeoVax Labs, Inc. stock is Buy, with an average 12-month price target of $100.00. In fiscal year 2025, GeoVax Labs, Inc. reported revenue of $2.5M and net income of -$21.5M. For detailed data — including GeoVax Labs, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GeoVax Labs, Inc. (GOVX) stock price is $1.34. The stock is traded on NASDAQ under the ticker symbol GOVX. The 52-week range is $0.96 – $34.75.